- Country: Poland
- Summary: Successive Delivery of a Medicinal Product Containing the Active Substance Nivolumab
- PLT Ref No: 74772593
- Deadline: 29 Nov 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 638408-2022
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- 1. The subject of the order is the successive delivery of a medicinal product containing the active substance nivolumab to the Hospital Pharmacy of the University Clinical Center in Gdańsk as part of the implementation of a non-commercial clinical trial: "Use of nivolumab (N) with subsequent chemotherapyiotherapy: bendamustine, gemcitabine and dexamethasone (BGD) with autologous bone marrow transplantation in patients with Hodgkin's lymphoma refractory to first-line treatment" („Nivolumab followed by bendamustine, gemcitabine and dexamethasone chemotherapy (BGD) and autologous hematopoietic cell transplantation in patients refractory to first line treatment") - 2020/ABM/01/00103.
Doc Title: Pharmaceutical products
Contract Type: Supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSuccessive Delivery of a Medicinal Product Containing the Active Substance Nivolumab - Poland Tender
The MEDICAL UNIVERSITY OF GDAŃSK, a Government sector organization in Poland, has announced a new tender for Successive Delivery of a Medicinal Product Containing the Active Substance Nivolumab. This tender is published on PolandTenders under PLT Ref No: 74772593 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-11-29.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
